openPR Logo
Press release

Injectable Drug Delivery Market 2018-2025 With Global Application Analysis, Substitute Study and Dominating Players Like Baxter International Inc., BD, Gerresheimer, Pfizer, SCHOTT, Alkermes, Eli Lilly and Company, Sandoz, Terumo Medical Corporation

09-27-2018 03:47 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Injectable Drug Delivery Market

Injectable Drug Delivery Market

Databridgemarketresearch.com adds “Injectable Drug Delivery Market 2018-2025 With Global Application Analysis, Substitute Study and Dominating Players Like Baxter International Inc., BD, Gerresheimer, Pfizer, SCHOTT, Alkermes, Eli Lilly and Company, Sandoz, Terumo Medical Corporation” reports to its database.

This report provides in depth study of “Injectable Drug Delivery Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Injectable Drug Delivery Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report focuses on the Injectable Drug Delivery Market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Global Injectable Drug Delivery Market development in North America, Europe, Asia-Pacific, South America, Middle East and Africa.

Download PDF Sample Copy of Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-injectable-drug-delivery-market

Some of the major players operating in global injectable drug delivery market are -

BD, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, Bespak, Baxter International, Inc., Nova Nordisk A/S, Sanofi, Crossject, InjexPharma GmbH, Elcam Medical, Unilife Corporation, West Pharmaceutical Services, Inc. and Vetter Pharma-Fertigung GmbH & Co. KG. among others.

Market Segmentation: Global Injectable Drug Delivery Market

By Type

• Injectable Drug Delivery Devices
• Injectable Drug Delivery Formulation
• Novel Drug Delivery Formulations

By Application

• Hormonal Disorders
• Oncology
• Autoimmune Diseases
• Orphan Disease
• Other Applications

By Usage Pattern

• Curative Care
• Immunizations
• Others

By Mode Of Administration

• Skin, Circulatory/ Muskoskeletal
• Organs
• Central Nervous System

By End User

• Hospitals And Clinics
• Home Healthcare Settings
• Research Laboratories
• Pharmaceutical and Biotechnological Companies
• Others

By Distribution Channel

• Hospital Pharmacy
• Pharmacy Stores
• Direct Tender
• Online Pharmacy

By Geography

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

To Avail 10% Discount On This Report Mail Us on: - sopan.gedam@databridgemarketresearch.com

Market Analysis: Global Injectable Drug Delivery Market

Global Injectable Drug Delivery Market is expected to reach USD 1,104,096.5 Million by 2025 from USD 378,998.2 Million in 2017, at a CAGR of 12.4% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.

Table of Contents:

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL INJECTABLE DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.2. RESTRAINTS

3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL INJECTABLE DRUG DELIVERY MARKET, REGULATORY

6.1. OVERVIEW

6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)

7. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE

7.1. OVERVIEW

7.2. INJECTABLE DRUG DELIVERY DEVICES

7.3. INJECTABLE DRUG DELIVERY FORMULATION

8. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS

8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES

8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS

9. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN

9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN

10. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION

10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM

11. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END USER

11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS

12. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

12.1. OVERVIEW

13. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY

13.1. OVERVIEW
13.2. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET

13.3. EUROPE INJECTABLE DRUG DELIVERY MARKET

13.4. APAC INJECTABLE DRUG DELIVERY MARKET

13.5. SOUTH AMERICA INJECTABLE DRUG DELIVERY MARKET

13.6. MEA INJECTABLE DRUG DELIVERY MARKET

14. GLOBAL INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE

14.1. COMPANY SHARE ANALYSIS: GLOBAL

15. COMPANY PROFILES

15.1. BECTON, DICKINSON AND COMPANY

15.2. PFIZER

15.3. BAXTER INTERNATIONAL

15.4. GERRESHEIMER AG

15.6. ALKERMES INC.

15.7. ANTARES PHARMA

15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)

15.9. ELCAM MEDICAL

15.10. ELI LILLY AND COMPANY

15.11. HASELMEIER

15.12. MYLAN N.V.

15.13. NOVO NORDISK

15.14. OWEN MUMFORD LTD

15.15. SANDOZ INTERNATIONAL GMBH

15.16. SANOFI

15.17. TERUMO CORPORATION

15.18. TEVA PHARMACEUTICAL

15.19. WEST PHARMACEUTICAL SERVICES, INC

15.20. YPSOMED HOLDING AG

16. RELATED REPORTS

Order a Copy of Global Injectable Drug Delivery Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-injectable-drug-delivery-market

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Injectable Drug Delivery Market 2018-2025 With Global Application Analysis, Substitute Study and Dominating Players Like Baxter International Inc., BD, Gerresheimer, Pfizer, SCHOTT, Alkermes, Eli Lilly and Company, Sandoz, Terumo Medical Corporation here

News-ID: 1267739 • Views: 355

More Releases from Data Bridge Market Research

Radiotherapy Market is Booming Worldwide With CIVCO Medical Solutions, Brainlab …
Global Radiotherapy Market is expected to reach at a CAGR of 7.7% in the forecast period of 2018 to 2025. Global Radiotherapy Market, By Therapy (Beam Radiotherapy, Brachytherapy, Systemic Radiotherapy), By Product Type (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Softwares, Systemic Radiotherapy), By Application (Prostrate Cancer, Breast Cancer, Lung Cancer, Spine Cancer, Liver Cancer, Brain Cancer, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) –
Cable Assembly Market Quantitative Analysis By TE Connectivity, Molex, LLC, W. L …
The cable assembly report aids in achieving an extreme sense of evolving industry movements before the competitors. This market research report gives clear idea about strategic analysis of mergers, expansions, acquisitions, partnerships, and investment. It becomes easy to analyse the actions of key players and its effect on the sales, import, export, revenue and CAGR values with this cable assembly report. The report is also a helpful source of assistance
Aroma Chemicals Market 2019:Quantitative Analysis By Hindustan Mint & Agro Produ …
The market analysis of aroma chemicals market report provides an examination of various market segments that are supposed to witness the fastest development amid the estimated forecast frame. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The best tools have been adopted to generate this report which is SWOT
Industrial Communication Market 2019:Industry Analysis By OMRON Corporation, Sch …
Global industrial communication market is set to witness a healthy CAGR of 11.12% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing adoption of industrial internet of things and increasing demand for wireless networks are the factor for the growth of this market. Industrial communication report is a well-generated market report which helps achieve comprehensive analysis of the market

All 5 Releases


More Releases for ELI

Global Insulin Market 2019 - Novo Nordisk, Eli Lilly, Sanofi-Aventis
This new report by Eon Market Research, titled “Global Insulin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Insulin industry at a global as well as regional and country level. Key facts analyzed in this report include the Insulin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Sarcoma Drugs Market – Qualitative Benefits 2028 | Novartis, Amgen, Eli Lilly
Global Sarcoma Drugs Market: Overview A sarcoma, a rare form of cancer, differs from the more common carcinomas in one major way – they occur in a different type of tissue known as connective tissue. Those are essentially cells that support or connect other types of tissue in the human body. Sarcoma is highly common in muscles, bones, fats, nerves, cartilage, and blood vessels in one’s arms and legs. They can,
Gout Therapeutics Market - Augmenting the demand 2025 | Novartis, Eli Lilly
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Global Feed Sweeteners Market 2018 - Biomin, DuPont, Eli Lilly, Ferrer
Apex Market Reports, recently published a detailed market research study focused on the “Feed Sweeteners Market” across the global, regional and country level. The report provides 360° analysis of “Feed Sweeteners Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Feed Sweeteners on
Insulin API Market 2017 - Ganlee, Sanofi, Novo Nordisk, Eli Lilly
Apex Market Researchs, recently published a detailed market research study focused on the "Insulin API Market" across the global, regional and country level. The report provides 360° analysis of "Insulin API Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Insulin API industry, and estimates the future trend of Insulin API market
Global Raloxifene Hydrochloride Market 2017 - Eli Lilly, InvaGen Pharmaceuticals
The report entitled Global Raloxifene Hydrochloride Market 2017 presents key insights into the global Raloxifene Hydrochloride market along with the latest up-to-date industry details and forthcoming Raloxifene Hydrochloride industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability. Report Keynotes: The main motive of the report on "Global Raloxifene Hydrochloride Market 2017" is to study comprehensive details of the market